Category:Repurposed Drugs: Difference between revisions
From Glioblastoma Treatments
Jump to navigationJump to search
No edit summary Tag: Reverted |
No edit summary |
||
| (4 intermediate revisions by the same user not shown) | |||
| Line 11: | Line 11: | ||
}} | }} | ||
[[Belongs to Grouping::Integrative Oncologist]] | [[Belongs to Grouping::Integrative Oncologist]] | ||
[[Category:TreatmentCategory]] | [[Category:TreatmentCategory]] | ||
Latest revision as of 06:41, 25 December 2024
Repurposed Drugs
Repurposed drugs are medications originally developed and approved for one condition but researched for potential effectiveness in treating other diseases, including cancer. Unlike **off-label use**, which refers to prescribing an approved drug for an unapproved indication based on clinician discretion, **drug repurposing** involves systematic research into new applications, often supported by laboratory studies, clinical trials, or emerging scientific evidence. Repurposed drugs may offer new treatment avenues with established safety profiles, which can reduce the time and cost of bringing these therapies into clinical practice.
List of Repurposed Drugs
Pages in category "Repurposed Drugs"
The following 17 pages are in this category, out of 17 total.
